Serina Therapeutics (SER) Interest Coverage Ratio (2021 - 2026)

Serina Therapeutics has disclosed Interest Coverage Ratio across 6 years of filings, most recently posting 33.42 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio rose 94.6% year-over-year to 33.42; the TTM figure through Jun 2026 stood at 59.97 (up 88.7% YoY), while the FY2025 annual figure was 112.78, down 247.97% from the prior year.
• Interest Coverage Ratio came in at 33.42 for Q2 2026 at Serina Therapeutics, down from 31.35 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 1.37 in Q4 2023 to a low of 1065.33 in Q3 2025.
• Average Interest Coverage Ratio over 5 years is 154.63, with a median of 12.54 recorded in 2024.
• Year-over-year, Interest Coverage Ratio surged 175.15% in 2023 and tumbled 23937.54% in 2024.
• Over 5 years, Interest Coverage Ratio stood at 1.82 in 2022, then surged by 175.15% to 1.37 in 2023, then plunged by 23937.54% to 326.41 in 2024, then soared by 90.4% to 31.35 in 2025, then declined by 6.6% to 33.42 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 33.42 in Q2 2026, 31.35 in Q4 2025, and 1065.33 in Q3 2025.